Shingrix Vaccine Linked to 24% Dementia Risk Reduction, Study Finds
A large-scale observational study published in the Annals of Internal Medicine reveals that the recombinant zoster vaccine, Shingrix, reduces the relative risk of developing dementia by around 24 percent among ... Read More